Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rahagir Salekeen, Michael S. Lustgarten, Umama Khan & Kazi Mohammed Didarul Islam. (2023) Model organism life extending therapeutics modulate diverse nodes in the drug-gene-microbe tripartite human longevity interactome. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-19.
Read now
Read now
Anna Bentke, Jędrzej Małecki, Barbara Ostrowska, Katarzyna Krzykowska-Petitjean & Piotr Laidler. (2013) Tanespimycin and Tipifarnib Exhibit Synergism in Inducing Apoptosis in Melanoma Cell Lines From Later Stages of Tumor Progression. Cancer Investigation 31:8, pages 545-549.
Read now
Read now
TaeHun Kim, Gyochang Keum & Ae Nim Pae. (2013) Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives. Expert Opinion on Therapeutic Patents 23:8, pages 919-943.
Read now
Read now
Articles from other publishers (53)
Xiaozheng Dou, Hui Guo, Terin D'Amico, Leah Abdallah, Chitra Subramanian, Bhargav A. Patel, Mark Cohen, John L. Rubinstein & Brian S. J. Blagg. (2023) CryoEM Structure with ATP Synthase Enables Late‐Stage Diversification of Cruentaren A. Chemistry – A European Journal 29:29.
Crossref
Crossref
Kristine Donahue, Haibo Xie, Miyang Li, Ang Gao, Min Ma, Yidan Wang, Rose Tipton, Nicole Semanik, Tina Primeau, Shunqiang Li, Lingjun Li, Weiping Tang & Wei Xu. (2022) Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment. Journal of Biological Chemistry 298:12, pages 102700.
Crossref
Crossref
Yuyi Yuan, Hui Wu, Bo Shuai, Chang Liu, Feng Zhu, Fei Gao, Chunzhu Wei & Heng Fan. (2022) Mechanism of HSP90 Inhibitor in the Treatment of DSS-induced Colitis in
Mice by Inhibiting MAPK Pathway and Synergistic Effect of Compound Sophora
Decoction. Current Pharmaceutical Design 28:42, pages 3456-3468.
Crossref
Crossref
Yuyang Peng, Huachun Yin, Song Li & Hui Yang. (2022) Transcriptome of pituitary function changes in rat model of high altitude cerebral edema. Genomics 114:6, pages 110519.
Crossref
Crossref
Su-Chan Lee, Lujain Alaali, HyukJean Kwon, Mohammed Rigi & Charles G. Eberhart. (2022) Cordycepin (3′-Deoxyadenosine) Suppresses Heat Shock Protein 90 Function and Targets Tumor Growth in an Adenosine Deaminase-Dependent Manner. Cancers 14:13, pages 3122.
Crossref
Crossref
Siddhi Omkar, Tasaduq H. Wani, Bo Zheng, Megan M. Mitchem & Andrew W. Truman. (2022) The APE2 Exonuclease Is a Client of the Hsp70–Hsp90 Axis in Yeast and Mammalian Cells. Biomolecules 12:7, pages 864.
Crossref
Crossref
Enrique L. Larghi, Alexandre Bruneau, Félix Sauvage, Mouad Alami, Juliette Vergnaud-Gauduchon & Samir Messaoudi. (2022) Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1H)-ones Bis-Heterocycles as Potential Inhibitors of the Protein Folding Machinery Hsp90. Molecules 27:2, pages 412.
Crossref
Crossref
Claudia Landi, Giulia Liberatori, Pietro Cotugno, Lucrezia Sturba, Maria Vannuccini, Federica Massari, Daniela Miniero, Angelo Tursi, Enxhi Shaba, Peter Behnisch, Alfonso Carleo, Fabrizio Di Giuseppe, Stefania Angelucci, Luca Bini & Ilaria Corsi. (2021) First Attempt to Couple Proteomics with the AhR Reporter Gene Bioassay in Soil Pollution Monitoring and Assessment. Toxics 10:1, pages 9.
Crossref
Crossref
Si-yuan Liang, Tong-chao Zhao, Zhi-hang Zhou, Wu-tong Ju, Ying Liu, Yi-ran Tan, Dong-wang Zhu, Zhi-yuan Zhang & Lai-ping Zhong. (2021) Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo. Translational Oncology 14:6, pages 101074.
Crossref
Crossref
Tao Feng, Dechao Wei, Qiankun Li, Xiaobing Yang, Yili Han, Yong Luo & Yongguang Jiang. (2021) Four Novel Prognostic Genes Related to Prostate Cancer Identified Using Co-expression Structure Network Analysis. Frontiers in Genetics 12.
Crossref
Crossref
Leilei Gou, Grace Gar-Lee Yue, Pema Tenzin Puno & Clara Bik-San Lau. (2021) A review on the relationship of mast cells and macrophages in breast cancer — Can herbs or natural products facilitate their anti-tumor effects?. Pharmacological Research 164, pages 105321.
Crossref
Crossref
Elisa Giorgio, Emanuela Pesce, Elisa Pozzi, Elvira Sondo, Marta Ferrero, Cristina Morerio, Giusy Borrelli, Edoardo Della Sala, Martina Lorenzati, Pietro Cortelli, Annalisa Buffo, Nicoletta Pedemonte & Alfredo Brusco. (2020) A high‐content drug screening strategy to identify protein level modulators for genetic diseases: A proof‐of‐principle in autosomal dominant leukodystrophy. Human Mutation 42:1, pages 102-116.
Crossref
Crossref
Sook-Kyoung Heo, Eui-Kyu Noh, Ho-Min Yu, Do Kyoung Kim, Hye Jin Seo, Yoo Jin Lee, Jaekyung Cheon, Su Jin Koh, Young Joo Min, Yunsuk Choi & Jae-Cheol Jo. (2020) Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death. BMC Cancer 20:1.
Crossref
Crossref
Peng Peng, Bin Zhang, Jingyuan Huang, Cong Xing, Weixiao Liu, Chao Sun, Wei Guo, Shengyu Yao, Wendong Ruan, Guangzhi Ning, Xiaohong Kong & Shiqing Feng. (2020) Identification of a circRNA-miRNA-mRNA network to explore the effects of circRNAs on pathogenesis and treatment of spinal cord injury. Life Sciences 257, pages 118039.
Crossref
Crossref
Huangyang MengJinhui LiuJiangnan QiuSipei NieYi JiangYicong WanWenjun Cheng. (2020) Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma. DNA and Cell Biology 39:5, pages 848-863.
Crossref
Crossref
Jinhui Liu, Huangyang Meng, Siyue Li, Yujie Shen, Hui Wang, Wu Shan, Jiangnan Qiu, Jie Zhang & Wenjun Cheng. (2019) Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis. Frontiers in Genetics 10.
Crossref
Crossref
Sona Talaei, Hassan Mellatyar, Asadollah Asadi, Abolfazl Akbarzadeh, Roghayeh Sheervalilou & Nosratollah Zarghami. (2019)
Spotlight on 17‐
AAG
as an Hsp90 inhibitor for molecular targeted cancer treatment
. Chemical Biology & Drug Design 93:5, pages 760-786.
Crossref
Crossref
Laura E. Knighton, Lena E. Delgado & Andrew W. Truman. (2018) Novel insights into molecular chaperone regulation of ribonucleotide reductase. Current Genetics 65:2, pages 477-482.
Crossref
Crossref
Isaac T. Sluder, Nitika, Laura E. Knighton & Andrew W. Truman. (2018) The Hsp70 co-chaperone Ydj1/HDJ2 regulates ribonucleotide reductase activity. PLOS Genetics 14:11, pages e1007462.
Crossref
Crossref
Jake Mazur, Kislay Roy & Jagat R Kanwar. (2018) Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine 13:1, pages 105-137.
Crossref
Crossref
Kourtney M. Goode, Dino P. Petrov, Renee E. Vickman, Scott A. Crist, Pete E. Pascuzzi, Tim L. Ratliff, V. Jo Davisson & Tony R. Hazbun. (2017) Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation. Biochimica et Biophysica Acta (BBA) - General Subjects 1861:8, pages 1992-2006.
Crossref
Crossref
D. J. Renouf, D. Hedley, M. K. Krzyzanowska, M. Schmuck, L. Wang & M. J. Moore. (2016) A phase II study of the HSP90 inhibitor AUY922 in chemotherapy refractory advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology 78:3, pages 541-545.
Crossref
Crossref
Jingbo Liu, Zhengqun Liu, Liang Chen & Hongfu Zhang. (2016) iTRAQ-based proteomic analysis reveals alterations in the liver induced by restricted meal frequency in a pig model. Nutrition 32:7-8, pages 871-876.
Crossref
Crossref
Bertan Bopp, Emanuele Ciglia, Anissa Ouald-Chaib, Georg Groth, Holger Gohlke & Joachim Jose. (2016) Design and biological testing of peptidic dimerization inhibitors of human Hsp90 that target the C-terminal domain. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:6, pages 1043-1055.
Crossref
Crossref
Su-Chan Lee, Hye-Young Min, Hoon Choi, Song Yi Bae, Kwan Hee Park, Seung Yeob Hyun, Ho Jin Lee, Jayoung Moon, Shin-Hyung Park, Jun Yong Kim, Hongchan An, So-Jung Park, Ji Hae Seo, Seungbeom Lee, Young-Myeong Kim, Hyun-Ju Park, Sang Kook Lee, Jeewoo Lee, Jeeyeon Lee, Kyu-Won Kim, Young-Ger Suh & Ho-Young Lee. (2016) Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity. Cancer Research 76:3, pages 686-699.
Crossref
Crossref
Torunn Wendel, Yan Zhen, Zenhe Suo, Skjalg Bruheim & Antoni Wiedlocha. (2016) The novel HSP90 inhibitor NVP-AUY922 shows synergistic anti-leukemic activity with cytarabine in vivo. Experimental Cell Research 340:2, pages 220-226.
Crossref
Crossref
Hee Joung Kim, Kye Young Lee, Young Whan Kim, Yun Jung Choi, Jung-Eun Lee, Chang Min Choi, In-Jeoung Baek, Jin Kyung Rho & Jae Cheol Lee. (2015) P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement. BMC Cancer 15:1.
Crossref
Crossref
Hak-Bong Kim, Su-Hoon Lee, Jee-Hyun Um, Won Keun Oh, Dong-Wan Kim, Chi-Dug Kang & Sun-Hee Kim. (2015) Sensitization of multidrug-resistant human cancer cells to Hsp90 inhibitors by down-regulation of SIRT1. Oncotarget 6:34, pages 36202-36218.
Crossref
Crossref
Shardule P. Shah, Sagar Lonial & Lawrence H. Boise. (2015) When Cancer Fights Back: Multiple Myeloma, Proteasome Inhibition, and the Heat-Shock Response. Molecular Cancer Research 13:8, pages 1163-1173.
Crossref
Crossref
Yu-Jia Chang, Chien-Yu Huang, Chin-Sheng Hung, Hui-Hsiung Liu & Po-Li Wei. (2015) Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells. Tumor Biology 36:6, pages 4367-4376.
Crossref
Crossref
Mackenzie D. Martin, Laurent Calcul, Courtney Smith, Umesh K. Jinwal, Sarah N. Fontaine, April Darling, Kent Seeley, Lukasz Wojtas, Malathi Narayan, Jason E. Gestwicki, Garry R. Smith, Allen B. Reitz, Bill J. Baker & Chad A. Dickey. (2015) Synthesis, Stereochemical Analysis, and Derivatization of Myricanol Provide New Probes That Promote Autophagic Tau Clearance. ACS Chemical Biology 10:4, pages 1099-1109.
Crossref
Crossref
A Spreafico, J-P Delord, L De Mattos-Arruda, Y Berge, J Rodon, E Cottura, P L Bedard, M Akimov, H Lu, S Pain, A Kaag, L L Siu & J Cortes. (2015) A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies. British Journal of Cancer 112:4, pages 650-659.
Crossref
Crossref
Susanta Sekhar Adhikari, Sujan Kumar Mondal & Rajkumar Banerjee. 2015. Heat Shock Protein-Based Therapies. Heat Shock Protein-Based Therapies
219
256
.
Si-Meng Chen, Chen-Liang Guo, Jia-Jie Shi, Yi-Chao Xu, Yi Chen, Yan-Yan Shen, Yi Su, Jian Ding & Ling-Hua Meng. (2014) HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer. International Journal of Cancer 135:10, pages 2462-2474.
Crossref
Crossref
Swee Sharp, Keith Jones & Paul Workman. 2014. Cancer Drug Design and Discovery. Cancer Drug Design and Discovery
239
274
.
Yu-Tzu Tai & Kenneth C. Anderson. 2013. Myeloma. Myeloma
110
120
.
Gaëtan Jego, Adonis Hazoumé, Renaud Seigneuric & Carmen Garrido. (2013) Targeting heat shock proteins in cancer. Cancer Letters 332:2, pages 275-285.
Crossref
Crossref
Lavanya Ramapathiran, Tytus Bernas, Franziska Walter, Linda Williams, Heiko Düssmann, Caoimhín G. Concannon & Jochen H. M. Prehn. (2013) Single cell imaging of the heat shock response during proteasome inhibitor-induced apoptosis in colon cancer cells suggests that magnitude and length rather than time of onset determines resistance to apoptosis. Journal of Cell Science.
Crossref
Crossref
Daniel R. Ciocca, Andre Patrick Arrigo & Stuart K. Calderwood. (2012) Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Archives of Toxicology 87:1, pages 19-48.
Crossref
Crossref
Sabrina Manni, Alessandra Brancalion, Laura Quotti Tubi, Anna Colpo, Laura Pavan, Anna Cabrelle, Elisa Ave, Fortunato Zaffino, Giovanni Di Maira, Maria Ruzzene, Fausto Adami, Renato Zambello, Maria Rita Pitari, Pierfrancesco Tassone, Lorenzo A. Pinna, Carmela Gurrieri, Gianpietro Semenzato & Francesco Piazza. (2012) Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress–Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response. Clinical Cancer Research 18:7, pages 1888-1900.
Crossref
Crossref
Carlos L. Arteaga, Mark X. Sliwkowski, C. Kent Osborne, Edith A. Perez, Fabio Puglisi & Luca Gianni. (2011) Treatment of HER2-positive breast cancer: current status and future perspectives. Nature Reviews Clinical Oncology 9:1, pages 16-32.
Crossref
Crossref
Hakan Kaya, Benjamin Peressini, Irfan Jawed, Danko Martincic, Ameer L. Elaimy, Wayne T. Lamoreaux, Robert K. Fairbanks, Kevin A. Weeks & Christopher M. Lee. (2011) Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients. International Journal of Hematology 95:1, pages 64-70.
Crossref
Crossref
Jinping Gan, Peggy Liu-Kreyche & W. Griffith Humphreys. (2011) In vitro assessment of cytochrome P450 inhibition and induction potential of tanespimycin and its major metabolite, 17-amino-17-demethoxygeldanamycin. Cancer Chemotherapy and Pharmacology 69:1, pages 51-56.
Crossref
Crossref
Jeffery D Eskew, Takrima Sadikot, Pedro Morales, Alicia Duren, Irene Dunwiddie, Megan Swink, Xiaoying Zhang, Stacey Hembruff, Alison Donnelly, Roger A Rajewski, Brian SJ Blagg, Jacob R Manjarrez, Robert L Matts, Jeffrey M Holzbeierlein & George A Vielhauer. (2011) Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells. BMC Cancer 11:1.
Crossref
Crossref
Cheryl A. London, Misty D. Bear, Jennifer McCleese, Kevin P. Foley, Reji Paalangara, Takayo Inoue, Weiwen Ying & James Barsoum. (2011) Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer. PLoS ONE 6:11, pages e27018.
Crossref
Crossref
Corrado TringaliJimmy Orjala, Nicholas Oberlies, Cedric Pearce, Steven Swanson & A Kinghorn. 2011. Bioactive Compounds from Natural Sources, Second Edition. Bioactive Compounds from Natural Sources, Second Edition
37
64
.
Philip C. De Witt Hamer, Shahryar E. Mir, David Noske, Cornelis J.F. Van Noorden & Tom Würdinger. (2011) WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe. Clinical Cancer Research 17:13, pages 4200-4207.
Crossref
Crossref
Meletios-Athanassios Dimopoulos, Constantine S. Mitsiades, Kenneth C. Anderson & Paul G. Richardson. (2011) Tanespimycin as Antitumor Therapy. Clinical Lymphoma Myeloma and Leukemia 11:1, pages 17-22.
Crossref
Crossref
Paul G. Richardson, Constantine S. Mitsiades, Jacob P. Laubach, Sagar Lonial, Asher A. Chanan-Khan & Kenneth C. Anderson. (2011) Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers. British Journal of Haematology 152:4, pages 367-379.
Crossref
Crossref
Catherine J. Huntoon, Monica D. Nye, Liyi Geng, Kevin L. Peterson, Karen S. Flatten, Paul Haluska, Scott H. Kaufmann & Larry M. Karnitz. (2010) Heat Shock Protein 90 Inhibition Depletes LATS1 and LATS2, Two Regulators of the Mammalian Hippo Tumor Suppressor Pathway. Cancer Research 70:21, pages 8642-8650.
Crossref
Crossref
Asher A. Chanan-Khan, Ivan Borrello, Kelvin P. Lee & Donna E. Reece. (2010) Development of target-specific treatments in multiple myeloma. British Journal of Haematology 151:1, pages 3-15.
Crossref
Crossref
Jane Trepel, Mehdi Mollapour, Giuseppe Giaccone & Len Neckers. (2010) Targeting the dynamic HSP90 complex in cancer. Nature Reviews Cancer 10:8, pages 537-549.
Crossref
Crossref
Ian J. Restall & Ian A. J. Lorimer. (2010) Induction of Premature Senescence by Hsp90 Inhibition in Small Cell Lung Cancer. PLoS ONE 5:6, pages e11076.
Crossref
Crossref